Trial Profile
Analysis for the efficacy and safety of peginterferon-alpha-2a monotherapy on chronic active hepatitis B patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2017
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 23 Dec 2017 Status changed from recruiting to completed.
- 01 Jul 2015 New trial record